×

ENTER REPORT NAME TO SEARCH

Global Pharmaceutical CDMO Services Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2201040191 | Category: Medical Care | Pages: 101 | Format: PDF | Published Date: July 11,2022


Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Pharmaceutical CDMO Services
    1.2 Classification of Pharmaceutical CDMO Services by Type
        1.2.1 Overview: Global Pharmaceutical CDMO Services Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Pharmaceutical CDMO Services Revenue Market Share by Type in 2021
        1.2.3 Drug Substance Development and Manufacturing
        1.2.4 Specialized Services
        1.2.5 Lab-based Services
    1.3 Global Pharmaceutical CDMO Services Market by Application
        1.3.1 Overview: Global Pharmaceutical CDMO Services Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Innovative Medicine
        1.3.3 Patented Drug
        1.3.4 Patent Expired Drug
    1.4 Global Pharmaceutical CDMO Services Market Size & Forecast
    1.5 Global Pharmaceutical CDMO Services Market Size and Forecast by Region
        1.5.1 Global Pharmaceutical CDMO Services Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Pharmaceutical CDMO Services Market Size by Region, (2017-2022)
        1.5.3 North America Pharmaceutical CDMO Services Market Size and Prospect (2017-2028)
        1.5.4 Europe Pharmaceutical CDMO Services Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Pharmaceutical CDMO Services Market Size and Prospect (2017-2028)
        1.5.6 South America Pharmaceutical CDMO Services Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Pharmaceutical CDMO Services Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Pharmaceutical CDMO Services Market Drivers
        1.6.2 Pharmaceutical CDMO Services Market Restraints
        1.6.3 Pharmaceutical CDMO Services Trends Analysis
2 Company Profiles
    2.1 Recipharm AB
        2.1.1 Recipharm AB Details
        2.1.2 Recipharm AB Major Business
        2.1.3 Recipharm AB Pharmaceutical CDMO Services Product and Solutions
        2.1.4 Recipharm AB Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Recipharm AB Recent Developments and Future Plans
    2.2 AMRI Global
        2.2.1 AMRI Global Details
        2.2.2 AMRI Global Major Business
        2.2.3 AMRI Global Pharmaceutical CDMO Services Product and Solutions
        2.2.4 AMRI Global Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 AMRI Global Recent Developments and Future Plans
    2.3 Patheon N.V.
        2.3.1 Patheon N.V. Details
        2.3.2 Patheon N.V. Major Business
        2.3.3 Patheon N.V. Pharmaceutical CDMO Services Product and Solutions
        2.3.4 Patheon N.V. Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Patheon N.V. Recent Developments and Future Plans
    2.4 Aenova Group
        2.4.1 Aenova Group Details
        2.4.2 Aenova Group Major Business
        2.4.3 Aenova Group Pharmaceutical CDMO Services Product and Solutions
        2.4.4 Aenova Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Aenova Group Recent Developments and Future Plans
    2.5 Catalent, Inc.
        2.5.1 Catalent, Inc. Details
        2.5.2 Catalent, Inc. Major Business
        2.5.3 Catalent, Inc. Pharmaceutical CDMO Services Product and Solutions
        2.5.4 Catalent, Inc. Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Catalent, Inc. Recent Developments and Future Plans
    2.6 Amatsigroup
        2.6.1 Amatsigroup Details
        2.6.2 Amatsigroup Major Business
        2.6.3 Amatsigroup Pharmaceutical CDMO Services Product and Solutions
        2.6.4 Amatsigroup Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Amatsigroup Recent Developments and Future Plans
    2.7 WuXi AppTec Group
        2.7.1 WuXi AppTec Group Details
        2.7.2 WuXi AppTec Group Major Business
        2.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Product and Solutions
        2.7.4 WuXi AppTec Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 WuXi AppTec Group Recent Developments and Future Plans
    2.8 Strides Pharma Science Limited
        2.8.1 Strides Pharma Science Limited Details
        2.8.2 Strides Pharma Science Limited Major Business
        2.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Product and Solutions
        2.8.4 Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Strides Pharma Science Limited Recent Developments and Future Plans
    2.9 Piramal Pharma Solutions
        2.9.1 Piramal Pharma Solutions Details
        2.9.2 Piramal Pharma Solutions Major Business
        2.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Product and Solutions
        2.9.4 Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Piramal Pharma Solutions Recent Developments and Future Plans
    2.10 Siegfried Ltd 
        2.10.1 Siegfried Ltd Details
        2.10.2 Siegfried Ltd Major Business
        2.10.3 Siegfried Ltd Pharmaceutical CDMO Services Product and Solutions
        2.10.4 Siegfried Ltd Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Siegfried Ltd Recent Developments and Future Plans
    2.11 Fareva Group
        2.11.1 Fareva Group Details
        2.11.2 Fareva Group Major Business
        2.11.3 Fareva Group Pharmaceutical CDMO Services Product and Solutions
        2.11.4 Fareva Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Fareva Group Recent Developments and Future Plans
    2.12 FAMAR Health Care Services
        2.12.1 FAMAR Health Care Services Details
        2.12.2 FAMAR Health Care Services Major Business
        2.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Product and Solutions
        2.12.4 FAMAR Health Care Services Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 FAMAR Health Care Services Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Pharmaceutical CDMO Services Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Pharmaceutical CDMO Services Players Market Share in 2021
        3.2.2 Top 10 Pharmaceutical CDMO Services Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Pharmaceutical CDMO Services Players Head Office, Products and Services Provided
    3.4 Pharmaceutical CDMO Services Mergers & Acquisitions
    3.5 Pharmaceutical CDMO Services New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Pharmaceutical CDMO Services Revenue and Market Share by Type (2017-2022)
    4.2 Global Pharmaceutical CDMO Services Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Pharmaceutical CDMO Services Revenue Market Share by Application (2017-2022)
    5.2 Global Pharmaceutical CDMO Services Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Pharmaceutical CDMO Services Revenue by Type (2017-2028)
    6.2 North America Pharmaceutical CDMO Services Revenue by Application (2017-2028)
    6.3 North America Pharmaceutical CDMO Services Market Size by Country
        6.3.1 North America Pharmaceutical CDMO Services Revenue by Country (2017-2028)
        6.3.2 United States Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        6.3.3 Canada Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        6.3.4 Mexico Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Pharmaceutical CDMO Services Revenue by Type (2017-2028)
    7.2 Europe Pharmaceutical CDMO Services Revenue by Application (2017-2028)
    7.3 Europe Pharmaceutical CDMO Services Market Size by Country
        7.3.1 Europe Pharmaceutical CDMO Services Revenue by Country (2017-2028)
        7.3.2 Germany Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        7.3.3 France Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        7.3.5 Russia Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        7.3.6 Italy Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Pharmaceutical CDMO Services Revenue by Type (2017-2028)
    8.2 Asia-Pacific Pharmaceutical CDMO Services Revenue by Application (2017-2028)
    8.3 Asia-Pacific Pharmaceutical CDMO Services Market Size by Region
        8.3.1 Asia-Pacific Pharmaceutical CDMO Services Revenue by Region (2017-2028)
        8.3.2 China Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        8.3.3 Japan Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        8.3.4 South Korea Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        8.3.5 India Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        8.3.7 Australia Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Pharmaceutical CDMO Services Revenue by Type (2017-2028)
    9.2 South America Pharmaceutical CDMO Services Revenue by Application (2017-2028)
    9.3 South America Pharmaceutical CDMO Services Market Size by Country
        9.3.1 South America Pharmaceutical CDMO Services Revenue by Country (2017-2028)
        9.3.2 Brazil Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        9.3.3 Argentina Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Pharmaceutical CDMO Services Revenue by Type (2017-2028)
    10.2 Middle East & Africa Pharmaceutical CDMO Services Revenue by Application (2017-2028)
    10.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Country
        10.3.1 Middle East & Africa Pharmaceutical CDMO Services Revenue by Country (2017-2028)
        10.3.2 Turkey Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        10.3.4 UAE Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer